Fair Value Measures and Disclosures - Schedule of Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Estimate of Fair Value Measurement | ||
| Fair value of financial instruments | ||
| Acquisition-related contingent consideration | $ 121,000 | $ 193,000 |
| Total liabilities | 121,000 | 193,000 |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Fair value of financial instruments | ||
| Acquisition-related contingent consideration | 0 | 0 |
| Total liabilities | 0 | 0 |
| Significant Other Observable Inputs (Level 2) | ||
| Fair value of financial instruments | ||
| Acquisition-related contingent consideration | 0 | 0 |
| Total liabilities | 0 | 0 |
| Significant Unobservable Inputs (Level 3) | ||
| Fair value of financial instruments | ||
| Acquisition-related contingent consideration | 121,000 | 193,000 |
| Total liabilities | $ 121,000 | $ 193,000 |
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|